Source: Rheumatology; Mar 2018; vol. 57 (no. 3); p. 470-479
Publication Date: Mar 2018
Publication Type(s): Academic Journal
Available at Rheumatology - from EBSCO (MEDLINE Complete)
Abstract:Objectives. To describe the baseline characteristics of SLE patients requiring biologic therapy in the UK and to explore short term efficacy and infection rates associated with rituximab (RTX) use.